Articles liés à Oxaprozin loaded solid lipid nanoparticles for management...
Oxaprozin loaded solid lipid nanoparticles for management of pain: Novel Development of Oxaprozin loaded Solid Lipid Nanoparticles for effective management of pain - Couverture souple
Synopsis
Solid lipid nanoparticles (SLN) introduced in 1991 represent an alternative carrier system to tradition colloidal carriers such as emulsions, liposomes and polymeric micro and nanoparticles. Nanoparticles made from solid lipids are attracting major attention as novel colloidal drug carrier for intravenous applications as they have been proposed as an alternative particulate carrier system. SLN are sub-micron colloidal carriers ranging from 50 to 1000 nm, which are composed of physiological lipid, dispersed in water or in aqueous surfactant solution. SLN offer unique properties such as small size, large surface area, high drug loading and the interaction of phases at the interface and are attractive for their potential to improve performance of pharmaceuticals. The Solid lipid nanoparticles were successfully developed for systemic delivery of Oxaprozin. SLN dispersions were prepared by solvent injection method. Physicochemical characterization including particle size, particle size distribution, Zeta potential, scanning electron microscopy and in-vitro release profile were carried out. In-vitro drug release pattern of optimized formulation of SLN showed fast and control release.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Résultats de recherche pour Oxaprozin loaded solid lipid nanoparticles for management...
Image fournie par le vendeur
Oxaprozin loaded solid lipid nanoparticles for management of pain
Edité par
LAP LAMBERT Academic Publishing Jan 2020, 2020
ISBN 10 : 6200507090
ISBN 13 : 9786200507099
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Solid lipid nanoparticles (SLN) introduced in 1991 represent an alternative carrier system to tradition colloidal carriers such as emulsions, liposomes and polymeric micro and nanoparticles. Nanoparticles made from solid lipids are attracting major attention as novel colloidal drug carrier for intravenous applications as they have been proposed as an alternative particulate carrier system. SLN are sub-micron colloidal carriers ranging from 50 to 1000 nm, which are composed of physiological lipid, dispersed in water or in aqueous surfactant solution. SLN offer unique properties such as small size, large surface area, high drug loading and the interaction of phases at the interface and are attractive for their potential to improve performance of pharmaceuticals. The Solid lipid nanoparticles were successfully developed for systemic delivery of Oxaprozin. SLN dispersions were prepared by solvent injection method. Physicochemical characterization including particle size, particle size distribution, Zeta potential, scanning electron microscopy and in-vitro release profile were carried out. In-vitro drug release pattern of optimized formulation of SLN showed fast and control release. 76 pp. Englisch. N° de réf. du vendeur 9786200507099
Acheter neuf
EUR 39,90
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Oxaprozin loaded solid lipid nanoparticles for management of pain
Edité par
LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6200507090
ISBN 13 : 9786200507099
Neuf
Couverture souple
Vendeur : moluna, Greven, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Dhote Vinod K.Prof. Vinod K Dhote & Prof. Kanika Dhote having nearly 10 years of academic & research experience in field of Pharmaceutical sciences. Both possessing research interest in formulation, development of pharmaceuticals and. N° de réf. du vendeur 385892728
Acheter neuf
EUR 34,25
Expédition à EUR 48,99
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Oxaprozin loaded solid lipid nanoparticles for management of pain : Novel Development of Oxaprozin loaded Solid Lipid Nanoparticles for effective management of pain
Edité par
LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6200507090
ISBN 13 : 9786200507099
Neuf
Taschenbuch
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Solid lipid nanoparticles (SLN) introduced in 1991 represent an alternative carrier system to tradition colloidal carriers such as emulsions, liposomes and polymeric micro and nanoparticles. Nanoparticles made from solid lipids are attracting major attention as novel colloidal drug carrier for intravenous applications as they have been proposed as an alternative particulate carrier system. SLN are sub-micron colloidal carriers ranging from 50 to 1000 nm, which are composed of physiological lipid, dispersed in water or in aqueous surfactant solution. SLN offer unique properties such as small size, large surface area, high drug loading and the interaction of phases at the interface and are attractive for their potential to improve performance of pharmaceuticals. The Solid lipid nanoparticles were successfully developed for systemic delivery of Oxaprozin. SLN dispersions were prepared by solvent injection method. Physicochemical characterization including particle size, particle size distribution, Zeta potential, scanning electron microscopy and in-vitro release profile were carried out. In-vitro drug release pattern of optimized formulation of SLN showed fast and control release. N° de réf. du vendeur 9786200507099
Acheter neuf
EUR 58,59
Expédition à EUR 35
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Oxaprozin loaded solid lipid nanoparticles for management of pain
Edité par
LAP LAMBERT Academic Publishing Jan 2020, 2020
ISBN 10 : 6200507090
ISBN 13 : 9786200507099
Neuf
Taschenbuch
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -Solid lipid nanoparticles (SLN) introduced in 1991 represent an alternative carrier system to tradition colloidal carriers such as emulsions, liposomes and polymeric micro and nanoparticles. Nanoparticles made from solid lipids are attracting major attention as novel colloidal drug carrier for intravenous applications as they have been proposed as an alternative particulate carrier system. SLN are sub-micron colloidal carriers ranging from 50 to 1000 nm, which are composed of physiological lipid, dispersed in water or in aqueous surfactant solution. SLN offer unique properties such as small size, large surface area, high drug loading and the interaction of phases at the interface and are attractive for their potential to improve performance of pharmaceuticals. The Solid lipid nanoparticles were successfully developed for systemic delivery of Oxaprozin. SLN dispersions were prepared by solvent injection method. Physicochemical characterization including particle size, particle size distribution, Zeta potential, scanning electron microscopy and in-vitro release profile were carried out. In-vitro drug release pattern of optimized formulation of SLN showed fast and control release.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 76 pp. Englisch. N° de réf. du vendeur 9786200507099
Acheter neuf
EUR 39,90
Expédition à EUR 60
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Oxaprozin loaded solid lipid nanoparticles for management of pain | Novel Development of Oxaprozin loaded Solid Lipid Nanoparticles for effective management of pain
Edité par
LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6200507090
ISBN 13 : 9786200507099
Neuf
Taschenbuch
Vendeur : preigu, Osnabrück, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. Oxaprozin loaded solid lipid nanoparticles for management of pain | Novel Development of Oxaprozin loaded Solid Lipid Nanoparticles for effective management of pain | Vinod K. Dhote (u. a.) | Taschenbuch | 76 S. | Englisch | 2020 | LAP LAMBERT Academic Publishing | EAN 9786200507099 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 117986899
Acheter neuf
EUR 36,35
Expédition à EUR 70
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 5 disponible(s)
Image d'archives
Oxaprozin loaded solid lipid nanoparticles for management of pain : Novel Development of Oxaprozin loaded Solid Lipid Nanoparticles for effective management of pain
Edité par
LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6200507090
ISBN 13 : 9786200507099
Ancien ou d'occasion
Couverture souple
Vendeur : Buchpark, Trebbin, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Solid lipid nanoparticles (SLN) introduced in 1991 represent an alternative carrier system to tradition colloidal carriers such as emulsions, liposomes and polymeric micro and nanoparticles. Nanoparticles made from solid lipids are attracting major attention as novel colloidal drug carrier for intravenous applications as they have been proposed as an alternative particulate carrier system. SLN are sub-micron colloidal carriers ranging from 50 to 1000 nm, which are composed of physiological lipid, dispersed in water or in aqueous surfactant solution. SLN offer unique properties such as small size, large surface area, high drug loading and the interaction of phases at the interface and are attractive for their potential to improve performance of pharmaceuticals. The Solid lipid nanoparticles were successfully developed for systemic delivery of Oxaprozin. SLN dispersions were prepared by solvent injection method. Physicochemical characterization including particle size, particle size distribution, Zeta potential, scanning electron microscopy and in-vitro release profile were carried out. In-vitro drug release pattern of optimized formulation of SLN showed fast and control release. N° de réf. du vendeur 36053776/2
Acheter D'occasion
EUR 33,59
Expédition à EUR 105
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Oxaprozin loaded solid lipid nanoparticles for management of pain : Novel Development of Oxaprozin loaded Solid Lipid Nanoparticles for effective management of pain
Edité par
LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6200507090
ISBN 13 : 9786200507099
Ancien ou d'occasion
Couverture souple
Vendeur : Buchpark, Trebbin, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Etat : Hervorragend. Zustand: Hervorragend | Sprache: Englisch | Produktart: Bücher | Solid lipid nanoparticles (SLN) introduced in 1991 represent an alternative carrier system to tradition colloidal carriers such as emulsions, liposomes and polymeric micro and nanoparticles. Nanoparticles made from solid lipids are attracting major attention as novel colloidal drug carrier for intravenous applications as they have been proposed as an alternative particulate carrier system. SLN are sub-micron colloidal carriers ranging from 50 to 1000 nm, which are composed of physiological lipid, dispersed in water or in aqueous surfactant solution. SLN offer unique properties such as small size, large surface area, high drug loading and the interaction of phases at the interface and are attractive for their potential to improve performance of pharmaceuticals. The Solid lipid nanoparticles were successfully developed for systemic delivery of Oxaprozin. SLN dispersions were prepared by solvent injection method. Physicochemical characterization including particle size, particle size distribution, Zeta potential, scanning electron microscopy and in-vitro release profile were carried out. In-vitro drug release pattern of optimized formulation of SLN showed fast and control release. N° de réf. du vendeur 36053776/1
Acheter D'occasion
EUR 34,60
Expédition à EUR 105
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image d'archives
Oxaprozin loaded solid lipid nanoparticles for management of pain: Novel Development of Oxaprozin loaded Solid Lipid Nanoparticles for effective management of pain
Edité par
LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 6200507090
ISBN 13 : 9786200507099
Neuf
paperback
Vendeur : Mispah books, Redhill, SURRE, Royaume-Uni
Évaluation du vendeur 4 sur 5 étoiles
paperback. Etat : New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book. N° de réf. du vendeur ERICA82962005070904
Acheter neuf
EUR 140,17
Expédition à EUR 29,08
Expédition depuis Royaume-Uni vers Etats-Unis
Expédition depuis Royaume-Uni vers Etats-Unis
Quantité disponible : 1 disponible(s)